Moderna Stock Plummets 17% on 2025 Sales Guidance Slash

22 hours ago · The company expects to end 2025 with cash, cash equivalents and investments of nearly $6 billion. Pipeline Updates Moderna reiterated its stance to launch 10 new marketed …

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

22 hours ago · The company expects to end 2025 with cash, cash equivalents and investments of nearly $6 billion. Pipeline Updates Moderna reiterated its stance to launch 10 new marketed …

yahoo.com

17%
OFF

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year. ... CNBC. Moderna stock plunges nearly 17% …

msn.com

17%
OFF

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

1 day ago · The crash in MRNA stock comes after the company slashed its outlook for 2024 and 2025 sales and also announced an expanded cost-cutting initiative. Moderna Stock Plummets …

zacks.com

39%
OFF

Moderna Stock Down 39% In Three Months: Buy The Dip Or Wait?

2 weeks from now

Dec 23, 2024 · The company reduced its overall R&D budget for the next four years (2025 to 2028) by nearly 20% to $16 billion. Management decided to discontinue five pipeline programs …

yahoo.com

8%
OFF

Moderna's Spending Cuts, Pipeline Shakeup Leave Doubts About A …

2 weeks from now

Sep 13, 2024 · One key concern: The company's full-year 2025 revenue guidance, issued Thursday, is nearly 8% lower, at the midpoint, than its full-year 2024 guidance - which was …

morningstar.com

17%
OFF

Moderna Inc (MRNA) Stock Price & News - Google Finance

2 weeks from now

Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion. 1 day ago. BioPharma Dive. ... Moderna lowers 2025 revenue estimate, announces more cost cuts.

google.com

$3
OFF

Moderna's Stock Slides As It Slashes Research Spending, Trims Pipeline

2 weeks from now

Sep 12, 2024 · In early August, Moderna's stock suffered its biggest-ever one-day decline after the company cut its full-year 2024 sales guidance to a range of $3 billion to $3.5 billion, down …

morningstar.com

21%
OFF

Why Moderna Stock Just Crashed 21% - The Motley Fool

2 weeks from now

2 days ago · The bad news is that as Moderna heads into the new year, it foresees continued sales declines in its vaccines business. 2025 sales estimates range from only $1.5 billion to …

fool.com

25%
OFF

Moderna Stock Plunges As Vaccine Maker Slashes R&D Budget

2 weeks from now

Sep 12, 2024 · In the release, Moderna also said it anticipates fiscal 2025 revenue to be in the range of $2.5 billion to $3.5 billion and sales to grow at a 25% compound annual growth rate …

kiplinger.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · Moderna expects to generate revenues between $2.5 billion and $3.5 billion in 2025. For 2026-2028, management expects sales to witness a CAGR of more than 25%, …

nasdaq.com

$2.53
OFF

Why Is Moderna Stock Trading Lower Today? - Benzinga

2 weeks from now

Nov 2, 2023 · Moderna Inc MRNA shares are trading lower after the company reported a deeper Q3 loss of $(9.53), down from EPS income of $2.53. The analysts' estimate stood at $(1.93). …

benzinga.com

17%
OFF

Moderna’s Stocks Plunge: Is This The End Or A Buying Opportunity?

2 weeks from now

3 hours ago · Following a disheartening business update shared at the J.P. Morgan Healthcare Conference, the company’s stock tumbled nearly 17%. This decline is part of a broader …

elblog.pl

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · The company reduced its overall R&D budget for the next four years (2025 to 2028) by nearly 20% to $16 billion. To meet these numbers, management decided to …

yahoo.com

17%
OFF

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

2 days ago · The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty ImagesModerna on Monday lowere …

stockxpo.com

FAQs about Moderna Stock Plummets 17% on 2025 Sales Guidance Slash Coupon?

Why did Moderna stock fall 17% on Monday?

Shares of Moderna were down nearly 17% on Monday, likely due to the guidance cut. This revised guidance fell significantly below Wall Street expectations. The Zacks Consensus Estimate for 2025 revenues is $2.94 billion. In the past year, the stock has plunged nearly 67% compared with the industry’s 16.3% fall. ...

Why did Moderna's stock price fall 17%?

Moderna’s (Nasdaq: MRNA) stock price fell 17% after it lowered its revenue guidance for 2025. Pictured: Moderna's headquarters at 325 Binney Street in Cambridge. Moderna Inc. entered the new year on the heels of a worsening stock performance in 2024. ...

Why is Moderna stock plunging?

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. ...

Why is Moderna (mRNA) stock plunging?

Moderna (MRNA) stock is plunging Thursday after the COVID-19 vaccine maker announced plans to slash research and development (R&D) expenses and instead focus on receiving approvals for the many drugs in its pipeline. Moderna's plans include a $1.1 billion reduction in R&D expenses by 2027 to a range of $3.6 billion to $3.8 billion. ...

How many analysts downgraded Moderna stock on Thursday?

Five analysts out of 25 downgraded Moderna stock on Thursday, according to FactSet. And 14 cut their price targets on shares. Moderna stock tumbled 2% to 68.28 on Friday. That followed a 12.4% dive on Thursday. It's not the first time Moderna's financial outlook has weighed on shares, William Blair analyst Myles Minter said. ...

Why is Moderna stock tumbling in 2024?

Weak adoption of Moderna’s respiratory syncytial virus (RSV) vaccine has exacerbated financial pressures, with the product contributing "minimal sales" in 2024. The announcement sent Moderna shares tumbling by 19 percent to $34.07 in early trading. ...